CA2992705A1 - Nanocapsule for delivery of lipophilic compound and process of preparation thereof - Google Patents

Nanocapsule for delivery of lipophilic compound and process of preparation thereof Download PDF

Info

Publication number
CA2992705A1
CA2992705A1 CA2992705A CA2992705A CA2992705A1 CA 2992705 A1 CA2992705 A1 CA 2992705A1 CA 2992705 A CA2992705 A CA 2992705A CA 2992705 A CA2992705 A CA 2992705A CA 2992705 A1 CA2992705 A1 CA 2992705A1
Authority
CA
Canada
Prior art keywords
capsules
sulfate
chitosan
oil
poly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA2992705A
Other languages
English (en)
French (fr)
Inventor
Szczepan Zapotoczny
Joanna SZAFRANIEC
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chde Polska Sa
Original Assignee
Uniwersytet Jagiellonski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagiellonski filed Critical Uniwersytet Jagiellonski
Publication of CA2992705A1 publication Critical patent/CA2992705A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA2992705A 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof Pending CA2992705A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL413155A PL229276B1 (pl) 2015-07-17 2015-07-17 Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania
PLP.413155 2015-07-17
PCT/PL2016/050032 WO2017014655A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof

Publications (1)

Publication Number Publication Date
CA2992705A1 true CA2992705A1 (en) 2017-01-26

Family

ID=56801756

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2992705A Pending CA2992705A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof

Country Status (11)

Country Link
US (2) US10821083B2 (https=)
EP (1) EP3324939A1 (https=)
JP (1) JP6971217B2 (https=)
KR (1) KR20180025318A (https=)
CN (1) CN107847441B (https=)
AU (4) AU2016295949A1 (https=)
CA (1) CA2992705A1 (https=)
MX (1) MX387005B (https=)
PL (1) PL229276B1 (https=)
RU (1) RU2723374C1 (https=)
WO (1) WO2017014655A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018176047A (ja) * 2017-04-10 2018-11-15 パナソニックＩｐマネジメント株式会社 マイクロカプセル及びマイクロカプセルの製造方法、並びに、化粧料及び化粧料の製造方法
CN109535430A (zh) * 2017-09-22 2019-03-29 天津大学 一种油酰化壳寡糖胍接枝聚乙烯亚胺的两亲性衍生物及其制备方法
ES2711669A1 (es) * 2017-11-02 2019-05-06 Univ Santiago Compostela Sistemas de liberacion de farmacos de acido polisialico y metodos
CN108246215B (zh) * 2017-12-21 2020-06-30 四川大学 一种超薄壁壳聚糖微囊及其制备方法
PL240632B1 (pl) * 2018-04-06 2022-05-09 Univ Jagiellonski Zastosowanie nanokapsuły z ciekłym rdzeniem olejowym w terapii przeciwnowotworowej
CN108739807B (zh) * 2018-06-21 2021-07-13 中国热带农业科学院农产品加工研究所 植物油酸-壳聚糖基纳米微胶囊农药、其制备方法及其应用
EP3836900A1 (en) * 2018-08-17 2021-06-23 Smela, Krzysztof Pawel Multicompartment system of nanocapsule-in-nanocapsule type, for encapsulation of a lipophilic and hydrophilic compound, and the related production method
CN109925983B (zh) * 2019-03-08 2021-12-28 紫罗兰家纺科技股份有限公司 基于乳木果油的双层微胶囊及其整理到纺织面料中的方法
CN111920782B (zh) * 2019-05-13 2025-11-18 中国医学科学院药物研究所 复合脂质纳米囊组合物及其制备方法和应用
CN112300767B (zh) * 2020-09-22 2022-04-05 山东大学 一种绿色靶向微胶囊及制备体系、制备方法和应用
EP4321175B1 (en) 2022-08-11 2025-07-16 CHDE Polska S.A. Magnetic polymer nanocapsules suitable for use in therapy, especially anti-cancer ones
PL446441A1 (pl) * 2023-10-20 2025-04-22 Chde Polska Spółka Akcyjna 2-metylo-3-fitylo-1,4-naftochinon do stosowania w leczeniu lub zapobieganiu chorób przebiegających z dysfunkcją śródbłonka naczyniowego

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2093562B1 (es) 1995-05-26 1997-07-01 Univ Santiago Compostela Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
US20060063676A1 (en) 2004-09-17 2006-03-23 Brigance Mickey R Method for enhancing deposition of an agrochemical
JP2009504805A (ja) 2005-08-09 2009-02-05 ナノバイオ コーポレーション 抗炎症活性を有するナノエマルジョン組成物
CN101410098B (zh) * 2006-01-23 2012-01-18 耶路撒冷希伯来大学伊森姆研究发展公司 包括含亲脂性药物的纳米胶囊的微球
ATE515260T1 (de) * 2006-03-13 2011-07-15 Advanced In Vitro Cell Technologies S L Stabile nanokapselsysteme für die verabreichung von wirkstoffen
EP2266546A1 (en) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
CN102161729B (zh) * 2011-02-25 2013-01-16 上海交通大学 水溶性多糖与疏水性单体形成纳米粒子的制备方法
ES2366255B2 (es) 2011-06-27 2012-08-08 Universidade De Santiago De Compostela Nanocomposiciones sacarídicas para la liberación de vacunas.
RU2494728C1 (ru) * 2012-08-16 2013-10-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Наноэмульсия, содержащая биологически активное вещество
CZ304654B6 (cs) * 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
JP2016531112A (ja) * 2013-07-25 2016-10-06 ネムコア メディカル イノベーションズ インコーポレイテッド 疎水性白金誘導体のナノエマルジョン

Also Published As

Publication number Publication date
EP3324939A1 (en) 2018-05-30
KR20180025318A (ko) 2018-03-08
US20180200197A1 (en) 2018-07-19
MX387005B (es) 2025-03-12
AU2016295949A1 (en) 2018-02-01
US20200345651A1 (en) 2020-11-05
AU2024201288A1 (en) 2024-03-14
PL413155A1 (pl) 2017-01-30
CN107847441A (zh) 2018-03-27
AU2021240279A1 (en) 2021-10-28
AU2026201122A1 (en) 2026-03-12
CN107847441B (zh) 2021-08-13
HK1251154A1 (zh) 2019-01-25
JP2018523642A (ja) 2018-08-23
JP6971217B2 (ja) 2021-11-24
MX2018000637A (es) 2018-09-06
US10821083B2 (en) 2020-11-03
PL229276B1 (pl) 2018-06-29
WO2017014655A1 (en) 2017-01-26
RU2723374C1 (ru) 2020-06-10

Similar Documents

Publication Publication Date Title
US20200345651A1 (en) Nanocapsule for delivery of lipophilic compound and process of preparation thereof
Mehandole et al. Core–shell type lipidic and polymeric nanocapsules: the transformative multifaceted delivery systems
Rafiee et al. Application of different nanocarriers for encapsulation of curcumin
Mazzarino et al. Elaboration of chitosan-coated nanoparticles loaded with curcumin for mucoadhesive applications
Panigrahi et al. Nanoencapsulation strategies for lipid-soluble vitamins
US20110033550A1 (en) Nanoparticle carriers for drug administration and process for producing same
Corrias et al. New methods for lipid nanoparticles preparation
Obeidat et al. Chitosan nanoparticles: approaches to preparation, key properties, drug delivery systems, and developments in therapeutic efficacy
Gagliardi et al. Easy preparation, characterization and cytotoxic investigation of 5-Fluorouracil-loaded zein/sericin nanoblends
Ali et al. Chitosan-Shea butter solid nanoparticles assemblies for the preparation of a novel nanoparticles in microparticles system containing curcumin
Wang et al. Emerging applications of Pickering emulsions in pharmaceutical formulations: A comprehensive review
Yadava et al. Low temperature, easy scaling up method for development of smart nanostructure hybrid lipid capsules for drug delivery application
Rochín-Wong et al. Lipid and polymeric nanocapsules
Sharma et al. Advancements in micellar formulation: drug delivery vehicle for water-insoluble drugs
Szafraniec et al. Chitosan-based nanocapsules of core-shell architecture
WO2007078060A1 (en) Polymer-liposome nano-complexes and the preparation method thereof, and the composition of skin external application containing the same
EP3752131B1 (en) Continuous process for coating liposomial vectors with polymer
Froiio et al. Polymer-based nanocontainers for drug delivery
WO2010046681A1 (en) Nanoparticles
HK1251154B (zh) 用於递送亲脂性化合物的纳米胶囊及其制备方法
Hassen et al. A literature review on the encapsulation process: advances, materials, and applications in modern industry
Aundhia Nanocapsules
Sarika et al. Alginate Based Micelle in Biomedical Applications
Piegat et al. Emulsification Parameters Study on Micelles Formation from Hydrophobically Modified Chitosan
Vu et al. Incorporation of nanomaterials into delivery systems of antioxidants: A review

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210709

C11 Application revival requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-C10-C11-C106 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUEST RECEIVED

Effective date: 20241008

C11 Application revival requested

Free format text: ST27 STATUS EVENT CODE: N-6-6-C10-C11-C106 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REINSTATEMENT REQUEST RECEIVED

Effective date: 20241106

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT

Effective date: 20250127

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 8TH ANNIV.) - STANDARD

Year of fee payment: 8

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250618

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250618

MFA Maintenance fee for application paid

Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 9TH ANNIV.) - STANDARD

Year of fee payment: 9

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250702

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: N-6-6-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250702

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260225